{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:59:09Z","timestamp":1780743549967,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370156"],"award-info":[{"award-number":["82370156"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"High-Level Overseas Talent Recruitment and Support Program","award":["High-Level Overseas Talent Recruitment and Support Program"],"award-info":[{"award-number":["High-Level Overseas Talent Recruitment and Support Program"]}]},{"name":"Key Joint Project of Heilongjiang Provincial Natural Science Foundation of China","award":["ZL2024H016"],"award-info":[{"award-number":["ZL2024H016"]}]},{"name":"the startup funding of the First Affiliated Hospital of Harbin Medical University","award":["RC-GCC2021-001"],"award-info":[{"award-number":["RC-GCC2021-001"]}]},{"name":"Research Operating Project of Heilongjiang Provincial Scientific Research Institutes","award":["Research Operating Project of Heilongjiang Provincial Scientific Research Institutes"],"award-info":[{"award-number":["Research Operating Project of Heilongjiang Provincial Scientific Research Institutes"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13258-026-01763-x","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T07:21:30Z","timestamp":1775719290000},"page":"935-949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SEMA4A promotes acute myeloid leukemia progression through inhibiting apoptosis"],"prefix":"10.1007","volume":"48","author":[{"given":"Xinyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruolin","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fukai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8250-3696","authenticated-orcid":false,"given":"Huitao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"1763_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrc2657","volume":"9","author":"T Abbas","year":"2009","unstructured":"Abbas T, Dutta A (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9:400\u2013414","journal-title":"Nat Rev Cancer"},{"key":"1763_CR2","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1182\/blood.2021015161","volume":"139","author":"GSF Anderson","year":"2022","unstructured":"Anderson GSF, Ballester-Beltran J, Giotopoulos G, Guerrero JA, Surget S, Williamson JC, So T, Bloxham D, Aubareda A, Asby R et al (2022) Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma. Blood 139:2471\u20132482","journal-title":"Blood"},{"key":"1763_CR3","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/art.41701","volume":"73","author":"J Avouac","year":"2021","unstructured":"Avouac J, Pezet S, Vandebeuque E, Orvain C, Gonzalez V, Marin G, Mouterde G, Daien C, Allanore Y (2021) Semaphorins: from angiogenesis to inflammation in rheumatoid arthritis. Arthritis Rheumatol 73:1579\u20131588","journal-title":"Arthritis Rheumatol"},{"key":"1763_CR4","doi-asserted-by":"publisher","first-page":"101870","DOI":"10.1016\/j.redox.2021.101870","volume":"42","author":"AC Boese","year":"2021","unstructured":"Boese AC, Kang S (2021) Mitochondrial metabolism-mediated redox regulation in cancer progression. Redox Biol 42:101870","journal-title":"Redox Biol"},{"key":"1763_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17:395\u2013417","journal-title":"Nat Rev Clin Oncol"},{"key":"1763_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature12428","volume":"501","author":"GM Delgoffe","year":"2013","unstructured":"Delgoffe GM, Woo SR, Turnis ME, Gravano DM, Guy C, Overacre AE, Bettini ML, Vogel P, Finkelstein D, Bonnevier J et al (2013) Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis. Nature 501:252\u2013256","journal-title":"Nature"},{"key":"1763_CR7","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","volume":"401","author":"CD DiNardo","year":"2023","unstructured":"DiNardo CD, Erba HP, Freeman SD, Wei AH (2023) Acute myeloid leukaemia. Lancet 401:2073\u20132086","journal-title":"Lancet"},{"key":"1763_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","volume":"133","author":"CD DiNardo","year":"2019","unstructured":"DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, Frankfurt O, Konopleva M, Wei AH, Kantarjian HM et al (2019) Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood 133:7\u201317","journal-title":"Blood"},{"key":"1763_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","volume":"45","author":"M Forsberg","year":"2024","unstructured":"Forsberg M, Konopleva M (2024) AML treatment: conventional chemotherapy and emerging novel agents. Trends Pharmacol Sci 45:430\u2013448","journal-title":"Trends Pharmacol Sci"},{"key":"1763_CR10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1182\/blood.2023022202","volume":"143","author":"H Gu","year":"2024","unstructured":"Gu H, Chen C, Hou ZS, He XD, Xie S, Ni J, Qian C, Cheng X, Jiang T, Yang C et al (2024) PI3Kgamma maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway. Blood 143:1965\u20131979","journal-title":"Blood"},{"key":"1763_CR11","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.clnves.2025.100007","volume":"1","author":"S Hou","year":"2025","unstructured":"Hou S, Liu J, Zhu Y (2025) Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia. Cell Investig 1:100007","journal-title":"Cell Investig"},{"key":"1763_CR12","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","volume":"57","author":"G Ichim","year":"2015","unstructured":"Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, Haller M, Riley JS, Mason SM, Athineos D et al (2015) Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death. Mol Cell 57:860\u2013872","journal-title":"Mol Cell"},{"key":"1763_CR13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1080\/19336918.2016.1215785","volume":"10","author":"D Ito","year":"2016","unstructured":"Ito D, Kumanogoh A (2016) The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems. Cell Adh Migr 10:692\u2013699","journal-title":"Cell Adh Migr"},{"key":"1763_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.10","volume":"2","author":"A Khwaja","year":"2016","unstructured":"Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, Bloomfield CD, Estey E, Burnett A, Cornelissen JJ et al (2016) Acute myeloid leukaemia. Nat Rev Dis Primers 2:V","journal-title":"Nat Rev Dis Primers"},{"key":"1763_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40364-025-00799-7","volume":"13","author":"J Kotulova","year":"2025","unstructured":"Kotulova J, Badurova K, Chyra Z, Sevcikova S, Garbova N, Jelinek T, Hajek R, Hrdinka M (2025) Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential. Biomark Res 13:92","journal-title":"Biomark Res"},{"key":"1763_CR16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01037","volume":"419","author":"A Kumanogoh","year":"2002","unstructured":"Kumanogoh A, Marukawa S, Suzuki K, Takegahara N, Watanabe C, Ch\u2019ng E, Ishida I, Fujimura H, Sakoda S, Yoshida K et al (2002) Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 419:629\u2013633","journal-title":"Nature"},{"key":"1763_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H (2021) Emerging agents and regimens for AML. J Hematol Oncol 14:49","journal-title":"J Hematol Oncol"},{"key":"1763_CR18","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12967-022-03500-w","volume":"20","author":"L Liu","year":"2022","unstructured":"Liu L, Yang L, Liu X, Liu M, Liu J, Feng X, Nie Z, Luo J (2022) SEMA4D\/PlexinB1 promotes AML progression via activation of PI3K\/Akt signaling. J Transl Med 20:304","journal-title":"J Transl Med"},{"key":"1763_CR19","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.7150\/jca.86739","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Tan W, Wang W, Feng T, Wang C, Wang L, Zhou W (2023) SEMA4A promotes prostate cancer invasion: Involvement of tumor microenvironment. J Cancer 14:2633\u20132643","journal-title":"J Cancer"},{"issue":"4","key":"1763_CR20","doi-asserted-by":"publisher","first-page":"100046","DOI":"10.1016\/j.clnves.2025.100046","volume":"1","author":"F Meng","year":"2025","unstructured":"Meng F, Li H, Wang Y, Zheng Z, Chen YJCI (2025) The mechanism of AKT activation in cancer. Cell Investig 1(4):100046","journal-title":"Cell Investig"},{"key":"1763_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","volume":"20","author":"A Moyer","year":"2025","unstructured":"Moyer A, Tanaka K, Cheng EH (2025) Apoptosis in cancer biology and therapy. Annu Rev Pathol Mech Dis 20:303\u2013328","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"1763_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1126\/sciadv.ade0718","volume":"9","author":"Y Naito","year":"2023","unstructured":"Naito Y, Koyama S, Masuhiro K, Hirai T, Uenami T, Inoue T, Osa A, Machiyama H, Watanabe G, Sax N et al (2023) Tumor-derived semaphorin 4A improves PD-1-blocking antibody efficacy by enhancing CD8(+) T cell cytotoxicity and proliferation. Sci Adv 9:10","journal-title":"Sci Adv"},{"key":"1763_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41419-024-06810-7","volume":"15","author":"GO Nwosu","year":"2024","unstructured":"Nwosu GO, Ross DM, Powell JA, Pitson SM (2024) Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia. Cell Death Dis 15:413","journal-title":"Cell Death Dis"},{"key":"1763_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.20517\/cdr.2021.125","volume":"5","author":"F Ong","year":"2022","unstructured":"Ong F, Kim K, Konopleva MY (2022) Venetoclax resistance: mechanistic insights and future strategies. Cancer Drug Resist 5:380\u2013400","journal-title":"Cancer Drug Resist"},{"key":"1763_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0959-4388(03)00003-5","volume":"13","author":"RJ Pasterkamp","year":"2003","unstructured":"Pasterkamp RJ, Kolodkin AL (2003) Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol 13:79\u201389","journal-title":"Curr Opin Neurobiol"},{"key":"1763_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.semcdb.2012.10.005","volume":"24","author":"M Rehman","year":"2013","unstructured":"Rehman M, Tamagnone L (2013) Semaphorins in cancer: biological mechanisms and therapeutic approaches. Semin Cell Dev Biol 24:179\u2013189","journal-title":"Semin Cell Dev Biol"},{"key":"1763_CR27","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1167\/iovs.04-0020","volume":"45","author":"DS Rice","year":"2004","unstructured":"Rice DS, Huang W, Jones HA, Hansen G, Ye GL, Xu N, Wilson EA, Troughton K, Vaddi K, Newton RC et al (2004) Severe retinal degeneration associated with disruption of semaphorin 4A. Invest Ophthalmol vis Sci 45:2767\u20132777","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1763_CR28","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1182\/blood.2020006785","volume":"138","author":"AW Roberts","year":"2021","unstructured":"Roberts AW, Wei AH, Huang DCS (2021) BCL2 and MCL1 inhibitors for hematologic malignancies. Blood 138:1120\u20131136","journal-title":"Blood"},{"key":"1763_CR29","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1038\/ncomms6191","volume":"5","author":"E Schulz","year":"2014","unstructured":"Schulz E, Klampfl P, Holzapfel S, Janecke AR, Ulz P, Renner W, Kashofer K, Nojima S, Leitner A, Zebisch A et al (2014) Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X. Nat Commun 5:5191","journal-title":"Nat Commun"},{"key":"1763_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","volume":"20","author":"R Singh","year":"2019","unstructured":"Singh R, Letai A, Sarosiek K (2019) Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins. Nat Rev Mol Cell Biol 20:175\u2013193","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1763_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1083\/jcb.201602002","volume":"216","author":"T Sun","year":"2017","unstructured":"Sun T, Yang L, Kaur H, Pestel J, Looso M, Nolte H, Krasel C, Heil D, Krishnan RK, Santoni MJ et al (2017) A reverse signaling pathway downstream of Sema4A controls cell migration via Scrib. J Cell Biol 216:199\u2013215","journal-title":"J Cell Biol"},{"key":"1763_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0962-8924(00)01816-X","volume":"10","author":"L Tamagnone","year":"2000","unstructured":"Tamagnone L, Comoglio PM (2000) Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol 10:377\u2013383","journal-title":"Trends Cell Biol"},{"key":"1763_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.canlet.2014.12.038","volume":"358","author":"H Tian","year":"2015","unstructured":"Tian H, Gao Z, Li H, Zhang B, Wang G, Zhang Q, Pei D, Zheng J (2015) DNA damage response\u2013a double-edged sword in cancer prevention and cancer therapy. Cancer Lett 358:8\u201316","journal-title":"Cancer Lett"},{"key":"1763_CR34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s43587-024-00798-7","volume":"5","author":"D Toghani","year":"2025","unstructured":"Toghani D, Gupte S, Zeng S, Mahammadov E, Crosse EI, Seyedhassantehrani N, Burns C, Gravano D, Radtke S, Kiem HP et al (2025) Niche-derived Semaphorin 4A safeguards functional identity of myeloid-biased hematopoietic stem cells. Nat Aging 5:558\u2013575","journal-title":"Nat Aging"},{"key":"1763_CR35","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1101\/gad.184481.111","volume":"26","author":"T Toyofuku","year":"2012","unstructured":"Toyofuku T, Nojima S, Ishikawa T, Takamatsu H, Tsujimura T, Uemura A, Matsuda J, Seki T, Kumanogoh A (2012) Endosomal sorting by Semaphorin 4A in retinal pigment epithelium supports photoreceptor survival. Genes Dev 26:816\u2013829","journal-title":"Genes Dev"},{"key":"1763_CR36","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/sj.emboj.7601589","volume":"26","author":"T Toyofuku","year":"2007","unstructured":"Toyofuku T, Yabuki M, Kamei J, Kamei M, Makino N, Kumanogoh A, Hori M (2007) Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J 26:1373\u20131384","journal-title":"EMBO J"},{"key":"1763_CR37","doi-asserted-by":"publisher","first-page":"e912","DOI":"10.1097\/HS9.0000000000000912","volume":"7","author":"AH Wei","year":"2023","unstructured":"Wei AH, Roberts AW (2023) BCL2 inhibition: a new paradigm for the treatment of AML and beyond. Hemasphere 7:e912","journal-title":"Hemasphere"},{"key":"1763_CR38","doi-asserted-by":"publisher","first-page":"e16292","DOI":"10.7717\/peerj.16292","volume":"11","author":"X Wei","year":"2023","unstructured":"Wei X, Liu Z, Shen Y, Dong H, Chen K, Shi X, Chen Y, Wang B, Dong S (2023) Semaphorin4A promotes lung cancer by activation of NF-kappaB pathway mediated by PlexinB1. PeerJ 11:e16292","journal-title":"PeerJ"},{"key":"1763_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS (2011) Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30:87","journal-title":"J Exp Clin Cancer Res"},{"key":"1763_CR40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd4337","volume":"13","author":"T Worzfeld","year":"2014","unstructured":"Worzfeld T, Offermanns S (2014) Semaphorins and Plexins as therapeutic targets. Nat Rev Drug Discov 13:603\u2013621","journal-title":"Nat Rev Drug Discov"},{"key":"1763_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/gb-2006-7-3-211","volume":"7","author":"U Yazdani","year":"2006","unstructured":"Yazdani U, Terman JR (2006) The Semaphorins. Genome Biol 7:211","journal-title":"Genome Biol"},{"key":"1763_CR42","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"DB Zorov","year":"2014","unstructured":"Zorov DB, Juhaszova M, Sollott SJ (2014) Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 94:909\u2013950","journal-title":"Physiol Rev"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01763-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-026-01763-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01763-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T10:02:41Z","timestamp":1780740161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13258-026-01763-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1763"],"URL":"https:\/\/doi.org\/10.1007\/s13258-026-01763-x","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were approved by and performed in accordance with the guidelines of the First Affiliated Hospital of Harbin Medical University Institutional Animal Care and Use Committee (IACUC) (2025014). Human AML samples and normal controls were collected from the First Affiliated Hospital of Harbin Medical University in China. The study was approved by the Research Ethics Committee and the Ethics Committee of the First Affiliated Hospital of Harbin Medical University (2022189).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}